OR10AK1P

Across TCGA pan-cancer cohorts, OR10AK1P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated OR10AK1P data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher OR10AK1P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR10AK1P expression acts as an unfavorable survival marker.

LIHC, PAAD, and UCEC are the cancer types where OR10AK1P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.059	0.775	<.001	90	view →
PAAD	OS	Tertile	II,III,IV	0.233	0.561	.001	72	view →
UCEC	DFS	Tertile	All	0.604	0.899	.002	48	view →
SKCM	OS	Tertile	III,IV	0.176	0.705	.002	33	view →
GBM	OS	Tertile	All	0.112	0.421	.017	18	view →
PCPG	DFS	Tertile	All	0.124	0.913	<.001	18	view →
THCA	DFS	Tertile	II,III,IV	0.131	0.764	.003	18	view →
LGG	DFS	Tertile	All	0.225	0.738	.014	18	view →
KIRP	OS	Tertile	All	0.290	0.730	.003	9	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

OR10AK1P–LIHC (OS)

Open the LIHC breakdown →